SCHEMBL10028210

SCHEMBL10028210

c1ccc2c(-c3ccc4oc5c6c7c(oc8c-6c4c3c3ccccc83)c(-c3ccc4c6ccccc6c6oc8ccc(-c9cccc%10ccccc9%10)c9c%10ccccc%10c%10oc3c4c6-c%10c89)ccc7c3ccccc53)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.38
CDC25A P30304 1/20 0.38
CDC25C P30307 1/20 0.38
ALOX5 P09917 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
ALDH1A1 P00352 5/20 0.35
HPGD P15428 5/20 0.35
HSD17B10 Q99714 5/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 3/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 2/20 0.34
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
CASP1 P29466 1/20 0.34
HIF1A Q16665 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028165 0.92 ARSA (0.43) ARSACDC25ACDC25CALOX5ALDH1A1
SCHEMBL10028208 0.83 CDC14B (0.36) ARSACDC25ACDC25CALOX5MAOA
SCHEMBL10028209 0.82 ALOX5 (0.43) ARSACDC25ACDC25CALOX5MAOA
SCHEMBL10028169 0.79 ALDH1A1 (0.42) ARSACDC25ACDC25CMAOAMAOB
SCHEMBL10028183 0.77 MAOA (0.40) ARSACDC25ACDC25CALOX5MAOA
SCHEMBL10028187 0.77 MAOA (0.40) ARSACDC25ACDC25CALOX5MAOA
SCHEMBL16801416 0.76 ALDH1A1 (0.48) ARSACDC25ACDC25CMAOAMAOB
SCHEMBL10028153 0.76 ALDH1A1 (0.38) ARSACDC25ACDC25CMAOAMAOB
SCHEMBL18820598 0.75 ALDH1A1 (0.47) ARSACDC25ACDC25CALOX5MAOA
SCHEMBL10028120 0.74 MAOA (0.42) MAOAMAOBALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
WO-2008011964-A1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 ARSA 1960/4885CDC25A 3550/4885CDC25C 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.